{"name":"Czech CLL Study Group","slug":"czech-cll-study-group","ticker":"","exchange":"","domain":"","description":"The Czech CLL Study Group is a research organization focused on the study and treatment of Chronic Lymphocytic Leukemia (CLL). It conducts clinical trials and develops therapeutic strategies to improve patient outcomes in CLL.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bendamustine and Rituximab","genericName":"Bendamustine and Rituximab","slug":"bendamustine-and-rituximab","indication":"Chronic lymphocytic leukemia (CLL)","status":"phase_2"}]}],"pipeline":[{"name":"Bendamustine and Rituximab","genericName":"Bendamustine and Rituximab","slug":"bendamustine-and-rituximab","phase":"phase_2","mechanism":"Bendamustine is a chemotherapy medication that interferes with DNA replication, while Rituximab is a monoclonal antibody that targets and depletes B cells.","indications":["Chronic lymphocytic leukemia (CLL)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdkVXekRhUXdrSTFMcUhWWG4tLWEwTWxBMGhBdGtoMVRIZElUbm9QWjluZWNIdmJGdjRjYnVicnQ3YzljcHJ3QW12TS00bWhxRmgtaTNFS2w0d3Vhdnp5WlJJRERfVldRMGRiRHBlTlV5SVdaYVBjdlVsRF9haDR0NWdUZHg5RmF2RUE3Y3NDM1ZValdRLVFMNEY5UDAxWVdmX0swekxBTVNjcWJkZ2NKSVExakF1ZTlZYzJVYWNJOVhiZjM4bEFlMm5rU1FUNHNHaC1HQg?oc=5","date":"2025-08-11","type":"trial","source":"Reuters","summary":"Exclusive: Medical journal rejects Kennedy's call for retraction of vaccine study - Reuters","headline":"Exclusive: Medical journal rejects Kennedy's call for retraction of vaccine study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMDE4RlU0c0Jnb1JlbnNpZ2hpRS0tbEF3MVJJdldwWnVDb09LNjc4MC1VVGRIckd0SGN3cDhhS0haMW1xTVJjOVMtVk8tZlJ3eWN5Y0RmUndvMHNGZW5vcXk2VDgtbTIwTDVfUkxUN2FlQnlINEc5WVBaNGd4TVBPNWJHT1k1QWRDcnJiWGZtZ25rVEtCbHZiZWRjaTR5UEN0Vzhhd0x3YnMwcUtjeXM4dVJXbWhxWHlLSXBLeFBHLTN6WjcyUC1yTFdqSTIxUFlf?oc=5","date":"2025-06-27","type":"pipeline","source":"Reuters","summary":"Meet the Americans who make their own weight-loss drugs - Reuters","headline":"Meet the Americans who make their own weight-loss drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8xY2JJUVViNWVWOTdyd3BSdllQZ1RheGZaVlNFS2RrS19SREpWSVVjNUgtaHQ5czVMQUNYc2xIYVNHYVI1WWJOdDVfdTVGUU1Zd0VGOVZMbnNpZXNjWEtZ?oc=5","date":"2021-11-01","type":"trial","source":"Nature","summary":"COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study - Nature","headline":"COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOc3IwRWJGVGMtR25DazNGOVBBQ0t5T3RxcmRKMXRBNVAtXzBFNEdxQWR6N1FRVUR0VFZ4MDlVVVRxZnliXzR6X19oZlNWSTMxUWNNc3lxSXF0NGliUnljbEUyTW5CeTlVc3BnZGJwWGROSmZFV1llNjUzZS1iUVduVjd1TGJKdnd4eDlXaHdKRnRMX0JHNTd0ZG9nU2M4SUdv0gGmAUFVX3lxTE1kREExN0RwbWEyR1dsa0VhYkJSQWR4cG9zTHk3TkV5ZlQtM1Jlc2xQV0ktejZHSFVJVFV1OWswdHEwcFFXMEh1bGstekFFQkUtWEw2dkF6VlFyYXhxS2ZfbVR0c2Y3WHhXMmp4UnQ1RldZUlBSUEtlU0tvek5FU0NTZ2RneHcwNFN6d3pOMUx3dDBaUF9CX2IwOXdXZDk5TVFWX1l6UEE?oc=5","date":"2020-12-14","type":"pipeline","source":"Masarykova univerzita","summary":"University spin-off to focus on developing new cancer drugs - Masarykova univerzita","headline":"University spin-off to focus on developing new cancer drugs","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}